ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,712, issued on Oct. 28, was assigned to Sanofi Mature IP (Gentilly, France).
"Antitumoral use of cabazitaxel" was invented by Sunil Gupta (Lexington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound of formula:which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment."
The patent was filed on July 20, 2023, under Application No. 18/224,122.
*For further information, includ...